Literature DB >> 28350041

Debunking the Myth of Wool Allergy: Reviewing the Evidence for Immune and Non-immune Cutaneous Reactions.

Michaela Zallmann1, Pete K Smith, Mimi L K Tang, Lynda J Spelman, Jennifer L Cahill, Gabriele Wortmann, Constance H Katelaris, Katrina J Allen, John C Su.   

Abstract

Although wool is commonly believed to cause irritant (non-immune) and hypersensitivity (immune) cutaneous reactions, the evidence basis for this belief and its validity for modern garments have not been critically examined. Publications from the last 100 years, using MEDLINE and Google Scholar, were analysed for evidence that wool causes cutaneous reactions, both immune-mediated (atopic dermatitis exacerbation, contact urticaria, allergic contact dermatitis) and non-immune-mediated (irritant contact dermatitis, itch). Secondary aims of this paper were to examine evidence that lanolin and textile-processing additives (formaldehyde, chromium) cause cutaneous reactions in the context of modern wool-processing techniques. Current evidence does not suggest that wool-fibre is a cutaneous allergen. Furthermore, contact allergy from lanolin, chromium and formaldehyde is highly unlikely with modern wool garments. Cutaneous irritation from wool relates to high fibre diameters (≥ 30-32 µm). Superfine and ultrafine Merino wool do not activate sufficient c-fibres to cause itch, are well tolerated and may benefit eczema management.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28350041     DOI: 10.2340/00015555-2655

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  2 in total

1.  Effects of Merino Wool on Atopic Dermatitis Using Clinical, Quality of Life, and Physiological Outcome Measures.

Authors:  Joseph F Fowler; Lynn M Fowler; Douglas Lorenz
Journal:  Dermatitis       Date:  2019 May/Jun       Impact factor: 4.845

Review 2.  Bio-Functional Textiles: Combining Pharmaceutical Nanocarriers with Fibrous Materials for Innovative Dermatological Therapies.

Authors:  Daniele Massella; Monica Argenziano; Ada Ferri; Jinping Guan; Stéphane Giraud; Roberta Cavalli; Antonello A Barresi; Fabien Salaün
Journal:  Pharmaceutics       Date:  2019-08-11       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.